North Lisbon University Hospital Centre (CHULN)

 

Introduction

Introduction

The North Lisbon University Hospital Center (CHULN) is one of the main hospitals of the Portuguese National Health Service (SNS), and results from the merge of two important public University Hospitals, Santa Maria Hospital and Pulido Valente Hospital

CHULN has considerable assets in human resources, applied technologies and in accumulated know-how along with the support it renders to the populations from its area of direct influence, and with the guarantee of a differentiated referencial response in multiple clinical areas, both national and internationally, including in the Portuguese-speaking African Countries (the “PALOP”).

By the end of 2020, the North Lisbon University Hospital Center had a total of 6.538 professionals, with over 1400 medical doctors, distributed across 11 Clinical Departments and 42 Clinical Units.

Heart and Vessels

Cardiology

Cardio-thoracic Surgery

Vascular Surgery

General Surgery

Surgical Specialities

Otorhinolaringology

Ophthalmology

Plastic Surgery

Stomatology

Orthopedy

Urology

Medical Specialities

Dermatology

Infeccious Diseases

Endocrinology

Gastroenterology

Immuno-allergology

Medicine

Nephrology 

Rheumatology

Compl. Diag. and Therapeutics

Histopathology

Radiology

Neurological radiology

Immuno-hemotherapy

Physical Med. & Rehabilitation

Laboratory Medicine

Neurosciences & Mental Health

Neurology

Neurosurgery

Psychiatry & Mental Health

Obstetrics, Gynecology and Reprod. Medicine

Obstetrics

Gynecology

Oncology

Hematology

Oncology

Radiotherapy

Pediatrics

Pediatric Surgery

Genetics

Pediatric Cardiology

Neonatology

Pediatrics

Pediatric Psychiatry

Thorax

Pneumology

Thoracic Surgery

Emergency & Intensive Care Medicine

Intensive Care Medicine

Central Emergency

 

Contacts

Contact Details

Innovation Department
e-mail: Este endereço de email está protegido contra piratas. Necessita ativar o JavaScript para o visualizar.

Hospital Administration
e-mail: Este endereço de email está protegido contra piratas. Necessita ativar o JavaScript para o visualizar.

Clinical Investigation Centre
e-mail: Este endereço de email está protegido contra piratas. Necessita ativar o JavaScript para o visualizar.

 

Activity 2020

Activity 2020

 

643.223
appointments
1.002
hospital beds
21.676
surgical
procedures
172.371
emergency
admissions
77.561
sessions
in day care
6.9 million
medical exams 
2.303
deliveries 
3 million
records of
patient data 
2.542
appointments
per day
31.339
inpatients
59%
ambulatorization
of elective procedures
471
admissions
per day
15.046
patients treated
in day care sessions

Lisbon Medical Academic Centre (CAML)

Lisbon Medical Academic Centre (CAML)

The LMCA integrates the three pillars of the Healthcare Innovation triangle, CHULN, iMM and the Faculty of Medicine.

The Faculty of Medicine of the University of Lisbon (FMUL) is an institution of higher education integrated in the Classical University of Lisbon.

The Institute of Molecular Medicine (iMM) is considered one of the leading institutes of biomedical research in the country. It is associated to the Ministry of Science, Technology and Higher Education.

CAML’s differentiated structure allows for the promotion and development of the academic dimension and qualification of clinical practice, the modernization and development of research, medical education and innovation of the health sciences in pre- and post-graduation.

 

National Reference Center

National Reference Centers

The Ministry of Health acknowledged the following national reference centres at CHULN:

Transplantation

Adults renal transplantation
Pediatrics renal tranplantation

Oncology

Pediatric Oncology – CNS cancer
Adult Oncology - esophageal cancer
Adult Oncology – bone and soft tissues sarcomas
Adult Oncology - rectal cancer
Adult Oncology - hepatobiliary / pancreatic cancer

Rare Diseases

Familiar paramyloidosis
Rare diseases - Hereditary diseases of metabolism
Refractory epilepsy
Congenital coagulopathies
Cystic fibrosis

Medical and Surgical Area

Structural intervention Cardiology
Congenital heart disease

Procedures

ECMO
Cochlear implants
Interventional Neuroradiology in Cerebrovascular disease

 

European Reference Networks

European Reference Networks

European Reference Networks (ERNs) involve more than 900 highly specialised health care teams, located in more than 300 hospitals in 26 European countries. The main mission of the ERNs is to help patients with rare or low-prevalence complex diseases. CHULN is an active member of the following ERNs. In addition, at the European level CHLUN is also an Associate Partner of InnoSTARS, EIT Health.

Pediatrics

Hereditary Metabolic Disorders – MetabERN
MetabERN I Amino and organic acid related disorders (AOA)
MetabERN I Carbohydrate, fatty acid oxidation and ketone bodies disorder (C-FAO)
MetabERN I Lysosomal storage disorders (LSD)
Pediatric transplantation of the kidney – ERN TRANSCHILD

Neurosciences

Rare craniofacial anomalies and ENT disorders – ERN CRANIO
Refractory epilepsy I Epilepsy – ERN EpiCARE

Oncology

Adult Oncology - esophageal cancer
Adult Oncology – bone and soft tissues sarcomas
Adult Oncology - rectal cancer
Adult Oncology - hepatobiliary / pancreatic cancer

Cardiology

Structural intervention Cardiology

Hematology

Graft versus host disease after hematopoietic progenitor
Transplantation - Euro GVHD

Reumatology and  Bone Met.

Connective tissue and Musculoskeletal Diseases – ERN ReCONNET

Clinical Investigation

Clinical Investigation Centre of Lisbon's Academic Medical Centre - CIC-CAML is a Clinical Research Center which aims to centralize all the clinical research management and activities in a recent infrastructure dedicated exclusively to the development and support of clinical trials.

As a Clinical Research Center (CRC), CIC-CAML has dedicated facilities to perform clinical research according to ICH-GCP Guidelines providing to the clinical investigators the necessary infrastructure and services for the support and conduct of high quality clinical trials, from Phase I to IV. CIC-CAML as an infrastructure devoted to centralize clinical research support with a management team including study coordinators and study-nurse staff, allowing enrolment of patients.

At the moment we are involved in more than 180 clinical trials (3 are phase I) and had more than 150 patients included in clinical trials in different therapeutic areas such as: Oncology, Rheumatology, Neurology and Pediatrics. We also conduct observational studies and some of these projects are investigator-initiated studies.